CO6410288A2 - Una formulación multivitamínica / mineral para combatir los efectos del estrés ambiental; mejorar la inmunidad y mejorar la energía y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega d - Google Patents

Una formulación multivitamínica / mineral para combatir los efectos del estrés ambiental; mejorar la inmunidad y mejorar la energía y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega d

Info

Publication number
CO6410288A2
CO6410288A2 CO11100472A CO11100472A CO6410288A2 CO 6410288 A2 CO6410288 A2 CO 6410288A2 CO 11100472 A CO11100472 A CO 11100472A CO 11100472 A CO11100472 A CO 11100472A CO 6410288 A2 CO6410288 A2 CO 6410288A2
Authority
CO
Colombia
Prior art keywords
effects
effective amount
improve
environmental stress
multivitaminal
Prior art date
Application number
CO11100472A
Other languages
English (en)
Spanish (es)
Inventor
Richard Cotter
Charles Mohs
Lisa Dispensa
Paula Ziegler
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of CO6410288A2 publication Critical patent/CO6410288A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S607/00—Surgery: light, thermal, and electrical application
    • Y10S607/90—Substance abuse therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CO11100472A 2009-01-23 2011-08-09 Una formulación multivitamínica / mineral para combatir los efectos del estrés ambiental; mejorar la inmunidad y mejorar la energía y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega d CO6410288A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14668909P 2009-01-23 2009-01-23

Publications (1)

Publication Number Publication Date
CO6410288A2 true CO6410288A2 (es) 2012-03-30

Family

ID=41718206

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11100472A CO6410288A2 (es) 2009-01-23 2011-08-09 Una formulación multivitamínica / mineral para combatir los efectos del estrés ambiental; mejorar la inmunidad y mejorar la energía y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega d

Country Status (19)

Country Link
US (1) US20110274791A1 (https=)
EP (1) EP2389177A1 (https=)
JP (2) JP5722797B2 (https=)
KR (3) KR20150016333A (https=)
CN (3) CN105815770A (https=)
AR (1) AR075149A1 (https=)
AU (1) AU2010206791B2 (https=)
BR (1) BRPI1007037A2 (https=)
CA (1) CA2746902C (https=)
CO (1) CO6410288A2 (https=)
IL (2) IL213793A (https=)
MX (1) MX2011007743A (https=)
MY (1) MY160706A (https=)
NZ (3) NZ593502A (https=)
RU (2) RU2484824C2 (https=)
SG (2) SG10201800064UA (https=)
TW (1) TWI612905B (https=)
WO (1) WO2010085530A1 (https=)
ZA (1) ZA201104318B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2573999C2 (ru) * 2014-03-21 2016-01-27 Омнифарма Юроп Лимитед Диетическая добавка в форме таблетки, содержащая йод и селен
JP7118425B2 (ja) * 2016-04-11 2022-08-16 バイチュラス バイオテック，ソシエダ リミタダ 脱毛の予防及び／又は治療のためのペプチド及び医薬組成物、栄養補助組成物、又は獣医学組成物
CN107252473A (zh) * 2017-06-16 2017-10-17 刘保凤 一种强身健体保健药酒及其制备方法
KR200491241Y1 (ko) 2018-07-06 2020-03-09 대흥물산 주식회사 휠이 부착된 미닫이형 방충망 장치
CN111838679A (zh) * 2020-07-23 2020-10-30 美国营养有限公司 一种新型高效营养膳食补充剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740373A (en) * 1986-05-27 1988-04-26 Usv Pharmaceutical Corporation Stabilization of multivitamin/trace elements formulations
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
US5932624A (en) * 1995-10-17 1999-08-03 Herbert; Victor D. Vitamin supplement composition
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
DE60007576D1 (de) * 1999-03-18 2004-02-12 Bristol Myers Squibb Co Vitamin Formulierung für kardiovaskuläre Gesundheit
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
US6299896B1 (en) * 2000-04-13 2001-10-09 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
US20040213857A1 (en) * 2003-04-17 2004-10-28 Boehringer Ingelheim International Gmbh Multi-vitamin and mineral supplement for pregnant women
PL1732605T3 (pl) * 2004-03-29 2019-09-30 Wyeth Llc Multiwitaminowe i mineralne suplementy odżywcze
US20060228431A1 (en) * 2005-04-07 2006-10-12 Eben David J Nutriceutical tea
CN1762380A (zh) * 2005-09-30 2006-04-26 烟台益生药业有限公司 一种纳米硒制品及其制备方法
WO2007094827A2 (en) * 2006-02-10 2007-08-23 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
RU2335925C2 (ru) * 2006-04-12 2008-10-20 Антон Викторович Сергеев Биологически активный препарат и способ его получения
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
CA2691691C (en) * 2007-06-20 2013-09-24 Seth J. Baum Compositions and methods of treating chronic kidney disease

Also Published As

Publication number Publication date
CA2746902A1 (en) 2010-07-29
JP2012515783A (ja) 2012-07-12
NZ618593A (en) 2015-05-29
MX2011007743A (es) 2011-09-06
RU2013119341A (ru) 2014-11-10
KR20110117685A (ko) 2011-10-27
NZ593502A (en) 2013-12-20
NZ705666A (en) 2016-06-24
WO2010085530A1 (en) 2010-07-29
MY160706A (en) 2017-03-15
EP2389177A1 (en) 2011-11-30
KR20150016333A (ko) 2015-02-11
RU2484824C2 (ru) 2013-06-20
CN105815770A (zh) 2016-08-03
AU2010206791A1 (en) 2011-07-07
TWI612905B (zh) 2018-02-01
JP2015007092A (ja) 2015-01-15
IL213793A0 (en) 2011-07-31
JP5722797B2 (ja) 2015-05-27
RU2011128131A (ru) 2013-02-27
CA2746902C (en) 2017-10-03
SG10201800064UA (en) 2018-02-27
CN102292082A (zh) 2011-12-21
IL240493A0 (en) 2015-09-24
BRPI1007037A2 (pt) 2020-08-11
AR075149A1 (es) 2011-03-09
KR20160130526A (ko) 2016-11-11
CN103622035A (zh) 2014-03-12
IL240493A (en) 2017-02-28
US20110274791A1 (en) 2011-11-10
AU2010206791B2 (en) 2014-09-18
SG172761A1 (en) 2011-08-29
TW201031343A (en) 2010-09-01
RU2665635C2 (ru) 2018-09-03
IL213793A (en) 2016-08-31
ZA201104318B (en) 2012-02-29

Similar Documents

Publication Publication Date Title
AR075048A1 (es) Suplementos nutricionales para individuos de 50 + para mejorar la vitalidad, inmunidad, salud ocular y osea
AR095104A1 (es) Método para disminuir el dolor articular inducido por el ejercicio en mamíferos no artríticos
CO6410288A2 (es) Una formulación multivitamínica / mineral para combatir los efectos del estrés ambiental; mejorar la inmunidad y mejorar la energía y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega d
MX2015007933A (es) Oligosacaridos de leche humana para mejorar sintomas de estres.
AR081551A1 (es) Composiciones y bebidas que comprenden nutrientes, vitaminas, azucares, cisteina y/o productos de azucar-cisteina
AR098653A1 (es) Composición útil para promover la fertilidad femenina, composición de combinación
ECSP15034601A (es) Composiciones nutricionales que contienen treonato de magnesio, y sus usos
BRPI1015300A2 (pt) "composição nutricional compreendendo um extrato de maçã e reduzindo os sintomas de alegria a alimentos, especialmente em crianças"
HRP20161447T1 (hr) Pripravak koji sadrži ekstrakt zelenog čaja i ekstrakt nara, namijenjen upotrebi u sprječavanju ili usporavanju napredovanja raka prostate
BR112016002578A2 (pt) composições e método para fabricar solução aquosa de aminoácidos
PE20150166A1 (es) Alimento para terapia nutricional del sida
PT2477633E (pt) Suplemento dietético que estimula a função sexual masculina
PH12015501803A1 (en) Oral electrolyte solution containing lactoferrin and uses thereof
WO2012119049A3 (en) Nutritional compositions comprising prune extract and bioavailable curcumin
CN103540458A (zh) 润肤提亮肤色洗面乳
Pal Role of yogic practice on physical health: a review
Zourbanos et al. Physical exercise as strategy in alcohol abuse treatment.
MX2013009993A (es) Celulas b. texasporus deficientes de esporulacion y metodos para inactivacion eficiente y rentable y su uso.
UA79076U (ru) Способ профилактики и лечения хронического катарального гингивита у детей с сопутствующим хроническим гастродуоденитом
Werner et al. Evaluation of Average Nutrient Intakes of Collegiate Athletes and ROTC Cadets and Midshipmen
RU2013132627A (ru) Способ повышения общей физической работоспособности спортсменов
CO6490121A1 (es) Proceso innovador que nos permite obtener un suplemento dietario activante celular
UA50454U (ru) Способ лечения и профилактики варрооза пчел
PL406630A1 (pl) Kompozycja suplementu diety
UA86230U (ru) Способ формирования неоциста после операций на органах малого таза

Legal Events

Date Code Title Description
FC Application refused